Ardelyx (ARDX) Resubmits New Drug Application to FDA.

WALTHAM, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize...

Psycheceutical Bioscience Inc.’s (BWVI) Novel Topical Ketamine Delivery.

Rick Doblin, Recently Visited one of Psycheceutical's Labs. Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes...
ARDX, Roland Rick Perry

And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.

LIVE QUOTE Ardelyx Enters the Danger Zone* With Tenapanor. The company produced favorable (albeit very technical) information (data) at the National Kidney Foundation 2023 Spring Clinical...

Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.

If we average out the two most recent price targets this month, we come out with a potential gain of 337% and that ain't...

Updating Coverage Report: Two Binary Events Rapidly Approaching Principal Solar (PSWW).

Electric Vehicle EV Engine ‘Retro-Fitting’ Company Nearing Commercialization Minerva Oil Field Deal Valued at $116 Million, Nearing Completion Principal Solar Incorporated is building a portfolio of...

Hidden Gem and a Monster in the Making? Beasley Broadcast Group (BBGI) $0.80

If They Simply Changed Their Name to Beasley Internet Group, it Could be Revalued 3-Fold Higher. We attended their Investor Dinner in Boca Raton...

Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment...

Topline Results anticipated by the end of Q2 2023 CRANFORD, N.J. , April 3, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced...

Smart for Life (SMFL) Reports Revenue Increases 96.9% to $17.8 Million for 2022

Smart for Life Reports 2022 Financial Results and Provides Business Update (Bolding by IA Editor) BOCA RATON, Fla., March 31, 2023 (GLOBE NEWSWIRE) -- Smart for...

Report: Think Equity Updates Society Pass (SOPA). $6.00 Price Target.

Think Equity: Society Pass (Nasdaq: SOPA) – Path to Profitability NEW YORK, NY, March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Think Equity, LLC (“Think Equity”)...

And We Have a $26.4 Billion Winning Trifecta!

THREE PREVIOUS WINNERS* Immunomedics (IMMU) $3 to $87 up 2,800%, a gain of $20.7 billion. Acquired by Gilead Sciences (GILD) Dicerna (DRNA) $3.30 to $38.25 up...

Latest article

GeoVax (GOVX) Monkeypox (MPOX) PowerPoint.

In a recent press release, GeoVax shared progress on their MPOX Vaccine and published a PowerPoint related to the their planned upcoming MonkeyPox related...

Rick Rule Symposium – Conference Cheat Sheet

Natural Resource Investing Symposium - Presenter Guide We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...

GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!

What an Entertaining Week! ..and it's only Thursday. LIVE QUOTE (MAY 18TH) (MAY 21ST) So Where Does That Leave us Today? Yes, it was a pleasant surprise to see GeoVax...